Search
No relevant pages have been found
Number of relevant news: 2
New drug for inherited breast and ovarian cancers shows promise in early trials
Olaparib, a new type of experimental drug called a PARP inhibitor, has shown promising... al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a... olaparib, breast cancer, ovarian...
New drug may help women with hereditary breast cancer
were given 100mg doses of a new drug called olaparib, while the other half received 400mg doses of the drug. Olaparib is one in a... breast cancer, PARP inhibitors, olaparib...